4D's MRx0004 improves inflammation in asthma model

4D Pharma plc (LSE:DDDD) said once-daily oral MRx0004 protected against airway inflammation by decreasing infiltration of both neutrophils and eosinophils in the lung bronchoalveolar lavage fluid of a house dust mite mouse model of severe asthma. Data were published in Scientific Reports...